دورية أكاديمية

DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?

التفاصيل البيبلوغرافية
العنوان: DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?
المؤلفون: de la Rubia, Javier1,2 (AUTHOR) delarubia_jav@gva.es, Such, Esperanza1 (AUTHOR)
المصدر: Leukemia & Lymphoma. Nov2010, Vol. 51 Issue 11, p1960-1961. 2p.
مصطلحات موضوعية: *MULTIPLE myeloma treatment, *THALIDOMIDE, *TUMOR growth, *PHOSPHOINOSITIDES, *B cell lymphoma, *DIAGNOSIS, *THERAPEUTICS
مستخلص: In this article, the author discusses the new target called DEPTOR expression and thalidomide response for the treatment of multiple myeloma. It says that the activation of phosphoinositide 3-kinase (PI3K) or Akt pathway adds to the constitution of a tumor cell. It mentions that thalidomide treatment helps suppress Akt signaling. Furthermore, the use of thalidomide treatment on patients that have high DEPTOR expression makes them survive longer than those with lower DEPTOR expression.
قاعدة البيانات: Academic Search Index
الوصف
تدمد:10428194
DOI:10.3109/10428194.2010.527410